Santander, N.; Figueroa, E.G.; González-Candia, A.; Maliqueo, M.; Echiburú, B.; Crisosto, N.; Salas-Pérez, F.
Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives. Antioxidants 2024, 13, 1168.
https://doi.org/10.3390/antiox13101168
AMA Style
Santander N, Figueroa EG, González-Candia A, Maliqueo M, Echiburú B, Crisosto N, Salas-Pérez F.
Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives. Antioxidants. 2024; 13(10):1168.
https://doi.org/10.3390/antiox13101168
Chicago/Turabian Style
Santander, Nicolás, Esteban G. Figueroa, Alejandro González-Candia, Manuel Maliqueo, Bárbara Echiburú, Nicolás Crisosto, and Francisca Salas-Pérez.
2024. "Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives" Antioxidants 13, no. 10: 1168.
https://doi.org/10.3390/antiox13101168
APA Style
Santander, N., Figueroa, E. G., González-Candia, A., Maliqueo, M., Echiburú, B., Crisosto, N., & Salas-Pérez, F.
(2024). Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives. Antioxidants, 13(10), 1168.
https://doi.org/10.3390/antiox13101168